EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Association of Anti-VEGF Therapy with Reported Ocular Adverse Events

Moiz Lakhani, Angela T H Kwan, Deeksha Kundapur, Marko M Popovic, Karim F Damji, Bernard R Hurley

Ophthalmology Retina · 2025

DOI: 10.1016/j.oret.2025.08.018 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Ophthalmology Retina, 2025. Verfasst von Moiz Lakhani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; The University of Ottawa Eye Institute, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Pharmacovigilance, Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors, Wet Macular Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceVascular Endothelial Growth Factor AAngiogenesis InhibitorsWet Macular DegenerationMacular EdemaHumansFemaleMaleAgedRanibizumabIntravitreal InjectionsRecombinant Fusion ProteinsAdverse Drug Reaction Reporting SystemsUnited StatesReceptors, Vascular Endothelial Growth FactorRetinal Vein OcclusionAged, 80 and overRetrospective StudiesMiddle AgedAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

Adverse eventsAnti-VEGF drugsFDA Adverse Event Reporting SystemPostmarketing pharmacovigilance analysis

Substanzen

Vascular Endothelial Growth Factor AAngiogenesis InhibitorsRanibizumabafliberceptRecombinant Fusion ProteinsReceptors, Vascular Endothelial Growth FactorbrolucizumabAntibodies, Monoclonal, HumanizedVEGFA protein, human

Autor:innen und Institutionen

  • Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; The University of Ottawa Eye Institute, Ottawa, Ontario, Canada.
  • The University of Ottawa Eye Institute, Ottawa, Ontario, Canada.
  • Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, Ontario, Canada.
  • Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alberta, Canada; Department of Ophthalmology and Visual Sciences, Aga Khan University, Karachi, Pakistan.
  • The University of Ottawa Eye Institute, Ottawa, Ontario, Canada. Electronic address: bhurley@toh.ca.

Zitieren

APA

Lakhani, M., Kwan, A. T. H., Kundapur, D., Popovic, M. M., Damji, K. F., & Hurley, B. R. (2025). Association of Anti-VEGF Therapy with Reported Ocular Adverse Events. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2025.08.018

Vancouver

Lakhani M, Kwan ATH, Kundapur D, Popovic MM, Damji KF, Hurley BR. Association of Anti-VEGF Therapy with Reported Ocular Adverse Events. Ophthalmology Retina. 2025. doi:10.1016/j.oret.2025.08.018

BibTeX
@article{Lakhani2025,
  author = {Lakhani, Moiz and Kwan, Angela T H and Kundapur, Deeksha and Popovic, Marko M and Damji, Karim F and Hurley, Bernard R},
  title = {Association of Anti-VEGF Therapy with Reported Ocular Adverse Events},
  journal = {Ophthalmology Retina},
  year = {2025},
  doi = {10.1016/j.oret.2025.08.018}
}
Kostenlos starten →